https://scholars.lib.ntu.edu.tw/handle/123456789/523422
標題: | Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer | 作者: | Tseng, S.-Ja Yang, Pan-Chyr Kempson I.M. Li H.-J. S.-JA TSENG PAN-CHYR YANG |
公開日期: | 2020 | 出版社: | Elsevier B.V. | 卷: | 324 | 起(迄)頁: | 482-492 | 來源出版物: | Journal of Controlled Release | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085949121&doi=10.1016%2fj.jconrel.2020.05.043&partnerID=40&md5=e1a6599cd4ef5f4588fe0de0b36ba6c1 https://scholars.lib.ntu.edu.tw/handle/123456789/523422 |
ISSN: | 0168-3659 | DOI: | 10.1016/j.jconrel.2020.05.043 | SDG/關鍵字: | Amino acids; Biological organs; Cell signaling; Drug products; Enzyme inhibition; Acquired resistance; Clinical efficacy; Efficient treatment; Epidermal growth factor receptors; Non small cell lung cancer; Sustained release; Therapeutic outcomes; Tyrosine kinase inhibitor; Diseases; antineoplastic agent; epidermal growth factor receptor; lactic acid; nanocarrier; nucleic acid; plasmid DNA; protein tyrosine kinase inhibitor; virus vector; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; cancer immunotherapy; cancer resistance; cytoreductive surgery; DNA transfection; drug formulation; gene mutation; human; in vitro study; in vivo study; metastasis; nanopharmaceutics; nanotechnology; non small cell lung cancer; nonhuman; oncolytic virotherapy; priority journal; Review; RNAi therapeutics; sustained drug release; treatment outcome; tumor microenvironment; drug resistance; genetics; lung tumor; mutation; non small cell lung cancer; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。